Abstract:Elevated C-reactive protein (CRP), IL-6 and retinol-binding protein 4 (RBP4) levels are associated with insulin resistance and diabetes mellitus. Phytoestrogens (including lignans and isoflavones) may enhance the management of diabetes and are hypothesized to act through inflammation pathways. The present study explored the effects of flaxseed-derived lignan on inflammatory factors and RBP4 concentrations in type 2 diabetics, who have higher levels of these biomarkers. Seventy community-dwelling diabetic patients (twenty-six men and forty-four post-menopausal women) with mild hypercholesterolaemia completed a randomized, double-blind, placebo-controlled, cross-over trial of supplementation with flaxseed-derived lignan capsules (360 mg/d) or placebo for 12 weeks, separated by an 8-week wash-out period. The participants maintained their habitual diets and levels of physical activity. Baseline to follow-up concentrations of CRP increased significantly within the placebo group (1.42 (SEM 0.19) v. 1.96 (SEM 0.22) mg/l, P<0.001), but were comparatively unchanged in the lignan-supplemented group (1.67 (SEM 0.19) v. 1.90 (SEM 0.26) mg/l, P=0.94); a significant difference was observed between treatments (-0.45 (95% CI -0.76, -0-08) mg/l, P=0.021). This effect was confined to women (P=0.016), but not observed in men (P=0.49). No between-treatment differences were found with regard to IL-6 or RBP4; though IL-6 concentrations increased significantly from baseline to follow-up in both groups (P=0.004 and P<0.001 following lignan and placebo treatments, respectively). The study suggests that lignan might modulate CRP levels in type 2 diabetics. These results need to be confirmed by further large clinical trials of longer duration.

The promising antioxidant effects of lignans: Nrf2 activation comes into view

[Study on Main Pharmacodynamic Effects for Schisandra Lignans Based Upon Network Pharmacology].

Antioxidant efficacy and the upregulation of Nrf2-mediated HO-1 expression by (+)-lariciresinol, a lignan isolated from Rubia philippinensis, through the activation of p38

Naturally Lignan-Rich Foods: A Dietary Tool for Health Promotion?

Targeting NF-B pathway by dietary lignans in inflammation: expanding roles of gut microbiota and metabolites

Targeting NF-κB pathway by dietary lignans in inflammation: expanding roles of gut microbiota and metabolites

Lignan: an important natural estrogen from plants

Distribution, biosynthesis and therapeutic potential of lignans

The Potential Role of Major Argan Oil Compounds as Nrf2 Regulators and Their Antioxidant Effects

The therapeutic effect of Loranthus parasiticus lignan derivatives on collagen-induced arthritis in rats through the SHBG/NFκB pathway

Luteolin Inhibits Nrf2 Leading to Negative Regulation of the Nrf2/Are Pathway and Sensitization of Human Lung Carcinoma A549 Cells to Therapeutic Drugs

Lignans Extracted from Eucommia Ulmoides Oliv. Protects Against AGEs-Induced Retinal Endothelial Cell Injury

New Lignans and Their Biological Activities.

Novel lignans from Syringa pinnatifolia and protective effect against H2O2-induced oxidative injury through regulating the expression of Nrf2/HO-1 in H9c2 cells

Lignans as multi‐targeted natural products in neurodegenerative diseases and depression: Recent perspectives

Advances in the Synthesis of Lignan Natural Products

Natural Lignans from Arctium Lappa As Antiaging Agents in Caenorhabditis Elegans

Novel Lignans from Syringa Pinnatifolia and Protective Effect Against H2O2-induced Oxidative Injury Through Regulating the Expression of Nrf-2/HO-1 in H9c2 Cells

Anticancer Potential of Flaxseed Lignans, Their Metabolites and Synthetic Counterparts in Relation with Molecular Targets: Current Challenges and Future Perspectives

Lignans: Quantitative Analysis of the Research Literature

Effects of a flaxseed-derived lignan supplement on C-reactive protein, IL-6 and retinol-binding protein 4 in type 2 diabetic patients.